ID/IQ parent award for phase I clinical trials for development of neurotherapeutics - PPD development, LP

Ended Awarded Last action

Contract number
HHSN271201600005I
Awardee
Awarding agency
Task orders
7 $11,018,761 obligated

Award facts

Opportunity
Combined order value
  • $11,018,761 Current, with exercised options
  • $18,002,574 Potential, with all options
Last date to order 100% complete
IDV ceiling 57% used
$19,500,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee

Award details come from SAM.gov/FPDS.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00011 $0
Other Administrative Action P00010 $0
Supplemental Agreement for work within scope P00009 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00007 $0
Other Administrative Action P00006 $0
Other Administrative Action P00005 · MOD P00005: far clause 52.204-25 - ID/IQ parent award for phase I clinical trials for development of neurotherapeutics $0
Other Administrative Action P00004 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Vendor DUNS or Name Change - Non-Novation 1 $0
Original award $0
Show all 12

Quick answers

Who was awarded contract HHSN271201600005I?

HHSN271201600005I was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on July 1, 2016.

How much is contract HHSN271201600005I worth?

Orders under HHSN271201600005I have obligated $11,018,761. Their combined potential value, with all options, is $18,002,574. HHSN271201600005I's own ceiling is $19,500,000.

How many orders have been placed under contract HHSN271201600005I?

7 orders have been placed under HHSN271201600005I, the latest on June 29, 2026.

Which agency awarded contract HHSN271201600005I?

National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201600005I, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

Who can order from contract HHSN271201600005I?

HHSN271201600005I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN271201600005I part of a contract vehicle?

Yes. HHSN271201600005I is part of Phase I Clinical Trials for Development of Neurotherapeutics.

Was contract HHSN271201600005I competed?

The extent of competition for HHSN271201600005I was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV